Company news, research breakthroughs, and major announcements across industries.

Home/Multimedia

Multimedia |Unicycive Therapeutics

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027

Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate NDA Resubmission and PDUFA Date of March 25, 2027
  • PublishedOctober 22, 2026 · 9:00 AM
  • IndustryMultimedia
  • LanguageEN

Published by JCN Newswire. Read the original announcement for the full release.

Read the full announcement →

Latest from leading organizations

Explore recent announcements by organization